24.2%
average loss at 48 weeks on the top dose in the phase 2 trial
Home Weight loss (GLP-1) Retatrutide
Retatrutide, Lilly's "triple-hormone" shot, produced some of the biggest weight loss ever seen in a trial. It is not approved yet. Tirzepatide, its closest relative, is available today from online programs.
24.2%
average loss at 48 weeks on the top dose in the phase 2 trial
Not yet
FDA-approved. Lilly plans to file in the first quarter of 2027
20.9%
average loss on tirzepatide (SURMOUNT-1), which you can start today
Tirzepatide is the closest option to retatrutide you can get now, prescribed online with the medication and delivery included.
Every program here is prescribed online by a US-licensed clinician, fills prescriptions through a licensed US pharmacy and lets you start without an office visit. Each card shows the price we read on the program's own site (or says when a program prices only after its intake) and what that price covers, and we keep the date of every read; some programs bill a membership and the medication separately, and the card says so. The label on each card says what that program stands out for. How we check prices and programs.


Comes asInjection

Comes asVial

Comes asInjection or drops or troche

Comes asInjection or drops

Comes asVial or under the tongue

Comes asVial
Comes asInjection

Comes asVial

Comes asInjection


Comes asInjection or under the tongue

Comes asInjection



Comes asVial
| Program | Medication | Starts at | Same price every dose | Trustpilot | Link |
|---|---|---|---|---|---|
| #1 BetterMe Rx | Compounded semaglutide and tirzepatide, shots or tablets | $99/mo 12-month plan | Not stated | — | Visit |
| #2 SnagRx | Compounded semaglutide and tirzepatide | $59/mo sale price | Yes | — | Visit |
| #3 Maximus | Compounded tirzepatide; also Wegovy, Zepbound, Foundayo | $99.99/mo 12-month plan | Yes | 4.4 on Trustpilot1,106 reviews · | Visit |
| #4 SHED | Compounded semaglutide and tirzepatide: shots, under-the-tongue drops, lozenges; Wegovy, Foundayo, Zepbound | $159/mo 12-month plan | Yes | 4.6 on Trustpilot1,084 reviews · | Visit |
| #5 Direct Meds | Compounded semaglutide and tirzepatide, shots or oral drops | $297/mo month to month | Yes | 4.5 on Trustpilot17,724 reviews · | Visit |
| #6 Lttl | Compounded semaglutide and tirzepatide | $99/mo month to month | Yes | — | Visit |
| #7 HealthRX | Compounded semaglutide and tirzepatide | $97/mo 12-month plan | Not stated | — | Visit |
| #8 Enhanced | Compounded tirzepatide and semaglutide; microdose plans | $215/mo 6-month plan | Not stated | — | Visit |
| #9 ReadyRx | Compounded semaglutide and tirzepatide | $199/mo quarterly plan | Not stated | 4.7 on Trustpilot1,179 reviews · | Visit |
| #10 Gala | Compounded tirzepatide and semaglutide | $69/mo starting at | Yes | 4.6 on Trustpilot4,257 reviews · | Visit |
| #11 TrimRx | Compounded semaglutide and tirzepatide, shots or oral | $179/mo starting at | Not stated | — | Visit |
| #12 Vital Step | Compounded semaglutide and tirzepatide, shots or tablets | $167/mo 1-year plan | Not stated | — | Visit |
| #13 Found | Compounded semaglutide and tirzepatide; brand-name Wegovy, Zepbound, Foundayo | $149/mo 12-month plan | Yes | 4.2 on Trustpilot776 reviews · | Visit |
| #14 Oak | Compounded semaglutide and tirzepatide; oral Wegovy, brand-name pens | $119/mo 12-month plan | Not stated | — | Visit |
| #15 Refills | Compounded semaglutide and tirzepatide; injections or oral | $99/mo 4-week supply | Yes | 4.2 on Trustpilot1,779 reviews · | Visit |
| #16 yourEra | Compounded semaglutide and tirzepatide | $96/mo 12-month plan | Yes | — | Visit |
Not legally as a prescription medicine. It is still being studied and is not FDA-approved. Vials sold online as "research" retatrutide are not approved for people.
Eli Lilly says it plans to ask the FDA for approval in the first quarter of 2027. An FDA review usually takes about a year, so the earliest realistic window is late 2027 or 2028.
Tirzepatide works on two hormone receptors (GLP-1 and GIP). Retatrutide adds a third (glucagon), which is why it is called a "triple agonist". Both are made by Lilly and taken as a weekly shot.
Tirzepatide is the closest option available today: it is approved, widely prescribed, and led to 20.9% average weight loss in its main trial. Compounded tirzepatide from online programs is the lowest-priced way to start.
Sources: Jastreboff et al., NEJM 2023 (retatrutide phase 2); Eli Lilly Q2 2026 results (SEC filing); Zepbound prescribing information 2026 (Table 2, Study 1); Jastreboff et al., NEJM 2022 (SURMOUNT-1).
Exclusive discounts, price-drop alerts and Black Friday deals before everyone else. Pick what your card covers.
Some deals and approvals apply only to certain ages, or only to men or women.
Unsubscribe in one click.
Popular with members right now: